SGS adds formulation development services and expands US lab

By Gareth Macdonald

- Last updated on GMT

Related tags: United states

SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois.

Company VP of business development - North America - Eric Hoffman told Outsourcing-pharma.com about the move at the Interphex tradeshow in New York last week, explaining that customer demand and the ability to be involved in projects at an earlier stage were the key motivations for the investment.

Demand from customers has been increasing for several years…as an analytical laboratory pre-formulation development typically takes place prior to the work we see from our customers and the number of our customers asking for these type of services made it a very logical decision for us.”

Hoffman added that the while the Lincolnshire, Illinois facility will be the base SGS also plans to offer formation development at one of its sites in Europe in due course.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more

Webinars